| Product Code: ETC13144444 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Genomic Tests Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Genomic Tests Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Genomic Tests Market Revenues & Volume, 2021 & 2031F |
3.3 North America Genomic Tests Market - Industry Life Cycle |
3.4 North America Genomic Tests Market - Porter's Five Forces |
3.5 North America Genomic Tests Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Genomic Tests Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Genomic Tests Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Genomic Tests Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America Genomic Tests Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Genomic Tests Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Genomic Tests Market Trends |
6 North America Genomic Tests Market, 2021 - 2031 |
6.1 North America Genomic Tests Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Genomic Tests Market, Revenues & Volume, By Predictive & Presymptomatic Testing, 2021 - 2031 |
6.1.3 North America Genomic Tests Market, Revenues & Volume, By Carrier Testing, 2021 - 2031 |
6.1.4 North America Genomic Tests Market, Revenues & Volume, By Prenatal & Newborn Testing, 2021 - 2031 |
6.1.5 North America Genomic Tests Market, Revenues & Volume, By Diagnostic TestingPharmacogenomic Testing, 2021 - 2031 |
6.1.6 North America Genomic Tests Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Genomic Tests Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Genomic Tests Market, Revenues & Volume, By Cytogenetic Testing, 2021 - 2031 |
6.2.3 North America Genomic Tests Market, Revenues & Volume, By Biochemical Testing, 2021 - 2031 |
6.2.4 North America Genomic Tests Market, Revenues & Volume, By Molecular Testing, 2021 - 2031 |
6.3 North America Genomic Tests Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Genomic Tests Market, Revenues & Volume, By Cancer diagnosis, 2021 - 2031 |
6.3.3 North America Genomic Tests Market, Revenues & Volume, By Genetic Disease Diagnosis, 2021 - 2031 |
6.3.4 North America Genomic Tests Market, Revenues & Volume, By Cardiovascular Disease Diagnosis, 2021 - 2031 |
6.3.5 North America Genomic Tests Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Genomic Tests Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Genomic Tests Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.4.3 North America Genomic Tests Market, Revenues & Volume, By Research Centers and Academic & Government Institutes, 2021 - 2031 |
6.4.4 North America Genomic Tests Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.4.5 North America Genomic Tests Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 North America Genomic Tests Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Genomic Tests Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Genomic Tests Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Genomic Tests Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Genomic Tests Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Genomic Tests Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Genomic Tests Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Genomic Tests Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Genomic Tests Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Genomic Tests Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) Genomic Tests Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada Genomic Tests Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America Genomic Tests Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Genomic Tests Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Genomic Tests Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Genomic Tests Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Genomic Tests Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Genomic Tests Market Key Performance Indicators |
9 North America Genomic Tests Market - Export/Import By Countries Assessment |
10 North America Genomic Tests Market - Opportunity Assessment |
10.1 North America Genomic Tests Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Genomic Tests Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Genomic Tests Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Genomic Tests Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America Genomic Tests Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Genomic Tests Market - Competitive Landscape |
11.1 North America Genomic Tests Market Revenue Share, By Companies, 2022 |
11.2 North America Genomic Tests Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here